Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%

Trials by Status

recruiting133%
completed267%

Recent Activity

1 active trials
Showing 3 of 3
completed

Adaptive Optics (AO) Analysis of Retinal Arteries in Patients With Recent Stroke (STROKAO)

NCT04712747
recruiting

Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma

NCT05264818
completed

Study of Vascular Endothelial Glycocalyx and Ophthalmic Injury, Prospective Cohort of Patients With Prolonged Post-COVID-19 Symptoms

NCT05235698

Clinical Trials (3)

Showing 3 of 3 trials
NCT04712747

Adaptive Optics (AO) Analysis of Retinal Arteries in Patients With Recent Stroke (STROKAO)

Completed
NCT05264818

Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma

Recruiting
NCT05235698

Study of Vascular Endothelial Glycocalyx and Ophthalmic Injury, Prospective Cohort of Patients With Prolonged Post-COVID-19 Symptoms

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3